PubRank

S Siragusa

Author PubWeight™ 29.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ 1998 6.07
2 Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study. J Thromb Haemost 2005 2.18
3 Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results. J Thromb Haemost 2012 2.04
4 Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients. Leukemia 2010 1.44
5 Rebuttal to: The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism. Thromb Haemost 2001 1.39
6 Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin. J Thromb Haemost 2009 1.06
7 Molecular and functional characterization of Lactobacillus sanfranciscensis strains isolated from sourdoughs. Int J Food Microbiol 2007 1.03
8 Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost 2012 0.99
9 IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 2010 0.96
10 Congenital absence of inferior vena cava. Lancet 2001 0.87
11 MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms. Leukemia 2010 0.87
12 NADP-glutamate dehydrogenase activity in nonstarter lactic acid bacteria: effects of temperature, pH and NaCl on enzyme activity and expression. J Appl Microbiol 2010 0.85
13 Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism. Thromb Haemost 1995 0.84
14 Genotypic and phenotypic diversity of Lactobacillus rossiae strains isolated from sourdough. J Appl Microbiol 2007 0.83
15 Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer. J Thromb Haemost 2011 0.83
16 Optimizing tumor-reactive γδ T cells for antibody-based cancer immunotherapy. Curr Mol Med 2010 0.82
17 Trisomy 11: prevalence among 22,403 unique patient cytogenetic studies and clinical correlates. Leukemia 2010 0.79
18 Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2009 0.79
19 Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management. Haemophilia 2007 0.79
20 Manufacture of Fior di Latte cheese by incorporation of probiotic lactobacilli. J Dairy Sci 2012 0.78
21 Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area. Dig Liver Dis 2001 0.77
22 Centella Asiatica Triterpenic Fraction (CATTF) reduces the number of circulating endothelial cells in subjects with post phlebitic syndrome. Haematologica 1992 0.77
23 Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. Haemophilia 2012 0.77
24 Evaluation of a soluble fibrin assay in patients with suspected pulmonary embolism. Thromb Haemost 1996 0.76
25 Evaluation of a soluble fibrin assay in patients with suspected deep vein thrombosis. Thromb Haemost 1995 0.76
26 Low molecular weight heparins could be important in cancer. BMJ 1999 0.75
27 Should superficial vein thrombosis of the proximal greater saphenous vein be objectively evaluated in emergency wards? Thromb Haemost 2000 0.75
28 Successful treatment of gastrointestinal bleeding with recombinant factor VIIa after kidney transplantation in patients with pancytopenia. Transplant Proc 2006 0.75
29 Early diagnosis of deep vein thrombosis following total hip replacement using impedance plethysmography: advantages and limitations of this approach. Ital J Orthop Traumatol 1992 0.75
30 The epidemiology of deep vein thrombosis and pulmonary embolism. Haematologica 1995 0.75
31 Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion. Haematologica 1997 0.75
32 Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins. Int Angiol 2009 0.75
33 Secondary prophylaxis of venous thromboembolism: rational use of oral anticoagulants. Haematologica 1995 0.75
34 Recurrent venous thromboembolism complicated by heparin-induced thrombocytopenia as a first manifestation of an occult cancer: a case report. Int J Immunopathol Pharmacol 2008 0.75
35 Endothelium and inflammation. Ann Cardiol Angeiol (Paris) 1991 0.75